We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+9.49%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$512M
AUM Growth
+$238M
Cap. Flow
+$1.67M
Cap. Flow %
0.33%
Top 10 Hldgs %
60.66%
Holding
62
New
15
Increased
14
Reduced
17
Closed
13

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$13.1M
2
LLY icon
Eli Lilly
LLY
+$8.03M
3
BMY icon
Bristol-Myers Squibb
BMY
+$5.54M
4
MRK icon
Merck
MRK
+$4.46M
5
CAH icon
Cardinal Health
CAH
+$3.8M

Top Sells

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$7.99M
2
ISRG icon
Intuitive Surgical
ISRG
+$7.39M
3
BDX icon
Becton Dickinson
BDX
+$7.29M
4
A icon
Agilent Technologies
A
+$6.14M
5
FMS icon
Fresenius Medical Care
FMS
+$5.35M

Sector Composition

Rank Sector Weight
1 Healthcare 54.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABT icon
26
Abbott
ABT
$190B
$5.8M 1.13%
50,000
-15,000
-23% -$1.75M
COR icon
27
Cencora
COR
$63.7B
$5.72M 1.12%
50,000
-7,500
-13% -$886K
BMY icon
28
Bristol-Myers Squibb
BMY
$130B
$5.68M 1.11%
+85,000
New +$5.54M
BAX icon
29
Baxter International
BAX
$14.3B
$5.63M 1.1%
70,000
-10,000
-13% -$839K
EHC icon
30
Encompass Health
EHC
$12.4B
$5.46M 1.07%
87,990
-25,140
-22% -$1.68M
MRK icon
31
Merck
MRK
$322B
$4.67M 0.91%
+60,000
New +$4.46M
BMRN icon
32
BioMarin Pharmaceuticals
BMRN
$13.5B
$4.59M 0.9%
55,000
-5,000
-8% -$396K
A icon
33
Agilent Technologies
A
$42.2B
$4.43M 0.87%
30,000
-45,000
-60% -$6.14M
GMED icon
34
Globus Medical
GMED
$11.4B
$4.26M 0.83%
55,000
-10,000
-15% -$711K
HRC
35
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$3.98M 0.78%
35,000
– –
ILMN icon
36
Illumina
ILMN
$29.1B
$3.79M 0.74%
+8,224
New +$3.31M
CAH icon
37
Cardinal Health
CAH
$55.9B
$3.71M 0.72%
+65,000
New +$3.8M
HOLX
38
DELISTED
Hologic
HOLX
$3.34M 0.65%
+50,000
New +$3.34M
SNY icon
39
Sanofi
SNY
$104B
$3.16M 0.62%
+60,000
New +$3.13M
SGEN
40
DELISTED
Seagen Inc. Common Stock
SGEN
$3.16M 0.62%
+20,000
New +$2.97M
MRTX
41
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$2.42M 0.47%
15,000
+5,000
+50% +$803K
TPTX
42
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$2.34M 0.46%
30,000
+17,000
+131% +$1.26M
ABBV icon
43
AbbVie
ABBV
$442B
$2.25M 0.44%
+20,000
New +$2.25M
QGEN icon
44
Qiagen
QGEN
$8.81B
$2.18M 0.43%
+42,437
New +$2.19M
SEM
45
DELISTED
Select Medical
SEM
$2.11M 0.41%
+92,800
New +$1.93M
SRPT icon
46
Sarepta Therapeutics
SRPT
$1.92B
$1.94M 0.38%
25,000
+5,000
+25% +$379K
ARGX icon
47
argenx
ARGX
$54.1B
$1.81M 0.35%
6,000
-500
-8% -$142K
SANA icon
48
Sana Biotechnology
SANA
$1.13B
$1.25M 0.24%
+63,446
New +$1.44M
EAR
49
DELISTED
Eargo, Inc. Common Stock
EAR
$870K 0.17%
+1,089
New +$913K
BDX icon
50
Becton Dickinson
BDX
$49.4B
– –
-30,750
Closed -$7.29M
1
2
3

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return
9C
9823 Capital Dallas, Texas $132M AUM
STFP
Signal Tree Financial Partners Copley, Ohio $132M AUM 15.43% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
AC
Aldebaran Capital Carmel, Indiana $131M AUM 34.7% 1-Year Est. Return

Sivik Global Healthcare's Q2 2021 Portfolio in Review

As of Q2 2021, Sivik Global Healthcare held 62 positions worth $512M, up 87% from $274M the previous quarter. Its ten largest holdings account for 61% of the portfolio.

Sivik Global Healthcare's Q2 2021 filing shows 15 new, 14 increased, 17 reduced and 13 closed positions. Its largest new stake was State Street SPDR S&P Biotech ETF: 100,000 shares worth $13.5M. The largest sale was Thermo Fisher Scientific, an estimated $7.99M.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, down from 99% a quarter earlier.

  • Sivik Global Healthcare's largest Q2 2021 buy was State Street SPDR S&P Biotech ETF: 100,000 shares worth $13.5M.
  • Sivik Global Healthcare added most to Johnson & Johnson in Q2 2021, an estimated $3.31M increase.
  • Sivik Global Healthcare's biggest Q2 2021 reduction was Agilent Technologies, cutting an estimated $6.14M.
  • Sivik Global Healthcare fully exited Thermo Fisher Scientific in Q2 2021, selling an estimated $7.99M.
  • Sivik Global Healthcare's ten largest holdings make up 61% of its $512M portfolio in Q2 2021.
  • Sivik Global Healthcare opened 15 new positions and closed 13 in Q2 2021.
  • Sivik Global Healthcare's portfolio value rose 87% quarter-over-quarter to $512M.

Based on Sivik Global Healthcare's 13F filing for Q2 2021, filed 10 Aug 2021.